Krka, d. d. Stock Forecast for 2023 - 2025 - 2030
Updated on 04/24/2024
Krka, d. d. Stock Forecast and Price Target
Krka, d. d.'s most recent price target of 142.50€ for 2024 was provided by renowned analysts over the past few months, with an average prediction of 142.50€. If this prediction is correct, Krka, d. d.'s stock could rise by 14 percent from its current trading price. The potential increase for the stock is 142.50€ per share, with a possible range of 114.00€ to 150.00€. If you're considering investing in KRKG stock, it's important to look at its competitors too.
14.00% Upside
Krka, d. d. Fair Value Forecast for 2023 - 2025 - 2030
Krka, d. d.'s Price has decreased by 100.00% In the last four years, from 90.29€ to 0.00€. Analysts predict that Krka, d. d.'s Fair Value will increase in the upcoming year, reaching 104.02€. This would represent an increase of 100.00%. Over the next seven years, experts predict that Krka, d. d.'s Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| TEVA Stock Forecast | Teva Pharmaceutical Industries | Outperform |
12
|
$13.01 | Buy/Sell | $11.59 | 22.98% |
| VTRS Stock Forecast | Viatris Inc | Hold |
8
|
$11.36 | Buy/Sell | $11.73 | 5.63% |
| 500124 Stock Forecast | Dr. Reddy's Laboratories | Hold |
18
|
Rp5.95k | Buy/Sell | Rp5.67k | 1.61% |
| HIK Stock Forecast | Hikma Pharmaceuticals PLC | Outperform |
18
|
£18.19 | Buy/Sell | £28.11 | 62.62% |
| APN Stock Forecast | Aspen Pharmacare Holdings | Outperform |
18
|
R213.74 | Buy/Sell | R202.49 | 8.61% |
Krka, d. d. Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Krka, d. d.'s Revenue has seen an increase, rising from 1.53€B to 1.81€B. This represents a growth of 17.68%. Analysts predict that Krka, d. d.'s Revenue will increase in the upcoming year, reaching 1.87€B. This would represent an increase of 3.53%. Over the next seven years, experts predict that Krka, d. d.'s Revenue will grow at a rate of 17.56%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| RICHTER Stock Forecast | Outperform |
18
|
Ft8.96k | Buy/Sell | Ft11.02k | 30.58% | |
| BHC Stock Forecast | Bausch Health Companies | Hold |
15
|
$8.53 | Buy/Sell | $9.50 | 11.37% |
| 506690 Stock Forecast | Unichem Laboratories | - |
8
|
Rp577.45 | Buy/Sell | Rp355.00 | -100.00% |
.jpg)
Krka, d. d. Dividend per Share Forecast for 2023 - 2025 - 2030
Krka, d. d.'s Dividend per Share has seen growth In the last two years, going from 5.00€ to 6.60€ – a gain of 32.00% In the next year, analysts believe that Dividend per Share will reach 7.07€ – an increase of 7.12%. For the next seven years, the forecast is forDividend per Share to grow by 15.21%.
Krka, d. d. EBITDA Forecast for 2023 - 2025 - 2030
Krka, d. d.'s EBITDA has grown in the last three years, jumping from 495.73€M to 504.22€M – an increase of 1.71%. In the next year, analysts predict that EBITDA will reach 539.64€M – an increase of 7.02%. For the next seven years, the forecast is for EBITDA to grow by 16.02%.
Krka, d. d. EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Krka, d. d.'s EBIT has increased by 3.27%, going from 386.97€M to 399.62€M. In the next year, analysts are expecting an increase in EBIT, predicting it will reach 419.56€M – an increase of 4.99%. The Krka, d. d. forecast is for EBIT to reach 430.68€M or grow by 7.77%.
Krka, d. d. EPS Price Prediction Forecast for 2023 - 2025 - 2030
Krka, d. d.'s EPS has decreased by 100.00% In the last four years, from 9.27€ to 0.00€. Analysts predict that Krka, d. d.'s EPS will increase in the upcoming year, reaching 10.68€. This would represent an increase of 100.00%. Over the next seven years, experts predict that Krka, d. d.'s EPS will grow at a rate of 100.00%.
.jpg)